Myroxylon pereirae (balsam of Peru): Still worth testing?
Contact Dermatitis
; 85(3): 269-273, 2021 Sep.
Article
em En
| MEDLINE
| ID: mdl-33748955
ABSTRACT
BACKGROUND:
Because Myroxylon pereirae (MP), or balsam of Peru, is nowadays almost not used "as such," and fragrance mix 1 (FM1) apparently is more sensitive in detecting fragrance allergy, the usefulness of testing MP in baseline series was recently questioned.OBJECTIVES:
Identification of the number of clinically relevant patch test reactions to MP not detected by FM1.METHODS:
Retrospective analysis of 12 030 patients patch tested with MP and FM1 for contact dermatitis between January 2018 and December 2019 in 13 Italian dermatology clinics.RESULTS:
Four hundred thirty-nine patients (3.6%) had a positive patch test reaction to MP; 437 (3.6%) had a positive patch test reaction to FM1. Positive reactions to both MP and FM1 were observed in 119 subjects (1.0%), 310 (2.6%) reacted to MP only, 304 (2.5%) to FM1 only, 5 to MP and sorbitan sesquioleate (SSO), 9 to FM1 and SSO, and 5 to MP, FM1, and SSO. Single sensitizations were clinically relevant in 75.2% of cases for MP (62.9% current, 12.3% past) and 76.3% for FM1 (70.1% current, 6.2% past).CONCLUSIONS:
Based on our results, MP appears to be still worth testing along with FM1 in baseline series, because it allows detection of a remarkable number of fragrance allergies, often relevant, which would be otherwise missed.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Bálsamos
/
Testes do Emplastro
/
Dermatite Alérgica de Contato
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
Limite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
País como assunto:
America do sul
/
Peru
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article